Moments like these are worth savoring.
Kudos to all the work behind this standing ovation for a long awaited and much needed move forward in pancreatic cancer treatment. #ASCO26
UCSF Helen Diller Family Comprehensive Cancer Center
Oncologists and researchers at the ASCO 2026 conference give a standing ovation after the experimental drug daraxonrasib nearly doubles survival in a metastatic pancreatic cancer trial! #AGoodPlace
Source: www.reddit.com/r/Damnthatsi...
